In vivo expression of antimicrobial peptides in atopic dermatitis

Experimental Dermatology

Volumn 25, Issue 1, 2016, Pages 3-9

  Clausen, Maja Lisa ^a   Slotved, H C ^b   Krogfelt, Karen A ^b   Andersen, Paal Skytt ^a,b   Agner, Tove ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

AD; AMP; Antimicrobial peptides; Atopic dermatitis

Indexed keywords

ADRENOMEDULLIN; BETA DEFENSIN 1; CALCINEURIN INHIBITOR; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CORTICOSTEROID; DEFENSIN; DERMCIDIN; ELAFIN; HUMAN BETA DEFENSIN 1; INTERLEUKIN 13; LIPID; LYSOZYME; MESSENGER RNA; PIMECROLIMUS; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE; RNASE7; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN;

ARTICLE; ATOPIC DERMATITIS; DISEASE SEVERITY; HUMAN; IN VIVO STUDY; KERATINOCYTE; MICROBIOME; MYCOSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS; SKIN BIOPSY; SKIN INFECTION; SYSTEMIC THERAPY; VACCINIA VIRUS; VIRUS REPLICATION; BIOPSY; BLOOD; CHEMISTRY; COMPLICATION; DERMATITIS, ATOPIC; GENE EXPRESSION REGULATION; METABOLISM; MICROBIOLOGY; MICROFLORA; SKIN; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION; UPREGULATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; BIOPSY; CALCINEURIN INHIBITORS; DERMATITIS, ATOPIC; GENE EXPRESSION REGULATION; HUMANS; MICROBIOTA; PSORIASIS; RNA, MESSENGER; SKIN; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 84954025596     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12831     Document Type: Article

References (145)

1. Bieber T. Ann Dermatol 2010: 22: 125-137.
2. Boguniewicz M, Leung D Y. Immunol Rev 2011: 242: 233-246.
3. Palmer C N, Irvine A D, Terron-Kwiatkowski A et al. Nat Genet 2006: 38: 441-446.
4. Morar N, Cookson W O C M, Harper J I et al. J Invest Dermatol 2007: 127: 1667-1672.
5. O'Regan G M, Irvine A D. Clin Exp Allergy 2010: 40: 965-972.
6. Agrawal R, Woodfolk J A. Curr Allergy Asthma Rep 2014: 14: 433.
7. Gallo R L. Exp Dermatol 2013: 22: 517.
8. Ganz T, Lehrer R I. Curr Opin Immunol 1998: 10: 41-44.
9. Lai Y, Gallo R L. Trends Immunol 2009: 30: 131-141.
10. Yang D, Chertov O, Bykovskaia S N et al. Science 1999: 286: 525-528.
11. Koczulla R, Von Degenfeld G, Kupatt C et al. J Clin Invest 2003: 111: 1665-1672.
12. Di Nardo A, Vitiello A, Gallo R L. J Immunol 2003: 170: 2274-2278.
13. Yang D, Chen Q, Chertov O et al. J Leukoc Biol 2000: 68: 9-14.
14. Izadpanah A, Gallo R L. J Am Acad Dermatol 2005: 52: 381-382.
15. Zasloff M. Nature 2002: 415: 389-395.
16. Nomura I, Goleva E, Howell M D et al. J Immunol 2003: 171: 3262-3269.
17. Howell M D, Novak N, Bieber T et al. J Invest Dermatol 2005: 125: 738-745.
18. Santoro D, Bunick D, Graves T K et al. Vet Dermatol 2013: 24: 39-47 e10.
19. Santoro D, Marsella R, Bunick D et al. Vet Immunol Immunopathol 2011: 144: 382-388.
20. Van Damme C M M, Willemse T, van Dijk A et al. Mol Immunol 2009: 46: 2449-2455.
21. Rieg S, Garbe C, Sauer B et al. Br J Dermatol 2004: 151: 534-539.
22. Lee D-Y, Yamasaki K, Rudsil J et al. J Invest Dermatol 2008: 128: 1863-1866.
23. Agerberth B, Charo J, Werr J et al. Blood 2000: 96: 3086-3093.
24. Vandamme D, Landuyt B, Luyten W et al. Cell Immunol 2012: 280: 22-35.
25. Braff M H, Bardan A, Nizet V et al. J Invest Dermatol 2005: 125: 9-13.
26. Harder J, Schroder J M. Chem Immunol Allergy 2005: 86: 22-41.
27. Elias P M. Semin Immunopathol 2007: 29: 3-14.
28. Brogden N K, Mehalick L, Fischer C L et al. Ski Pharmacol Physiol 2012: 25: 167-181.
29. Metz-Boutigue M H, Shooshtarizadeh P, Prevost G et al. Curr Pharm Des 2010: 16: 1024-1039.
30. Afshar M, Gallo R L. Vet Dermatol 2013: 24: 32-39.
31. Schittek B. Curr Probl Dermatol 2011: 41: 54-67.
32. Schröder J M, Harder J. Cell Mol Life Sci 2006: 63: 469-486.
33. Oppenheim J J, Yang D. Curr Opin Immunol 2005: 17: 359-365.
34. Chen X, Niyonsaba F, Ushio H et al. J Dermatol Sci 2005: 40: 123-132.
35. Fritz P, Beck-Jendroschek V, Brasch J. Med Mycol 2012: 50: 579-584.
36. Feng Z, Jiang B, Chandra J et al. J Dent Res 2005: 84: 445-450.
37. Harder J, Bartels J, Christophers E et al. J Biol Chem 2001: 276: 5707-5713.
38. Harder J, Bartels J, Christophers E et al. Nature 1997: 387: 861.
39. Kisich K O, Carspecken C W, Fiéve S et al. J Allergy Clin Immunol 2008: 122: 62-68.
40. García J R, Jaumann F, Schulz S et al. Cell Tissue Res 2001: 306: 257-264.
41. Gallo R L, Murakami M, Ohtake T et al. J Allergy Clin Immunol 2002: 110: 823-831.
42. Lai Y, Cogen A L, Radek K A et al. J Invest Dermatol 2010: 130: 2211-2221.
43. Wittersheim M, Cordes J, Meyer-Hoffert U et al. Exp Dermatol 2013: 22: 364-366.
44. Midorikawa K, Ouhara K, Komatsuzawa H et al. Infect Immun 2003: 71: 3730-3739.
45. Schroeder B O, Wu Z, Nuding S et al. Nature 2011: 469: 419-423.
46. Goo J, Ji J H, Jeon H et al. Pediatr Dermatol 2010: 27: 341-348.
47. De Jongh G J, Zeeuwen P L J M, Kucharekova M et al. J Invest Dermatol 2005: 125: 1163-1173.
48. Gambichler T, Skrygan M, Tomi N S et al. Int Arch Allergy Immunol 2008: 147: 17-24.
49. Frohm M, Agerberth B, Ahangari G et al. J Biol Chem 1997: 272: 15258-15263.
50. Howell M D, Jones J F, Kisich K O et al. J Immunol 2004: 172: 1763-1767.
51. Braff M H, Hawkins M A, Di Nardo A et al. J Immunol 2005: 174: 4271-4278.
52. Turner J, Cho Y, Dinh N et al. Antimicrob Agents Chemother 1998: 42: 2203-2214.
53. Howell M D, Wollenberg A, Gallo R L et al. J Allergy Clin Immunol 2006: 117: 836-841.
54. Murakami M, Ohtake T, Dorschner R A et al. J Invest Dermatol 2002: 119: 1090-1095.
55. Ong P Y, Ohtake T, Brandt C et al. N Engl J Med 2002: 347: 1151-1160.
56. Yang D, Oppenheim J J. Arthritis Rheum 2004: 50: 3401-3403.
57. Kahlenberg J M, Kaplan M J. J Immunol 2013: 191: 4895-4901.
58. Harder J, Dressel S, Wittersheim M et al. J Invest Dermatol 2010: 130: 1355-1364.
59. Gläser R, Meyer-Hoffert U, Harder J et al. J Invest Dermatol 2009: 129: 641-649.
60. Gläser R, Köten B, Wittersheim M et al. J Dtsch Dermatol Ges 2011: 9: 897-902.
61. Gläser R, Harder J, Lange H et al. Nat Immunol 2005: 6: 57-64.
62. Zheng Y, Niyonsaba F, Ushio H et al. Immunology 2008: 124: 357-367.
63. Jinquan T. J Invest Dermatol 1996: 107: 5-10.
64. Harder J, Schroder J-M. J Biol Chem 2002: 277: 46779-46784.
65. Simanski M, Dressel S, Gläser R et al. J Invest Dermatol 2010: 130: 2836-2838.
66. Köten B, Simanski M, Gläser R et al. PLoS ONE 2009: 4: e6424.
67. Rieg S, Steffen H, Seeber S et al. J Immunol 2005: 174: 8003-8010.
68. Schittek B, Hipfel R, Sauer B et al. Nat Immunol 2001: 2: 1133-1137.
69. Asano S, Ichikawa Y, Kumagai T et al. Br J Dermatol 2008: 159: 97-104.
70. Clausen M L, Jungersted J M, Andersen P S et al. Br J Dermatol 2013: 169: 587-593.
71. Hata T R, Kotol P, Boguniewicz M et al. Br J Dermatol 2010: 659: 659-661.
72. Howell M D, Boguniewicz M, Pastore S et al. Clin Immunol 2006: 121: 332-338.
73. Maier T, Güell M, Serrano L. FEBS Lett 2009: 583: 3966-3973.
74. Vogel C, Marcotte E M. Nat Rev Genet 2012: 13: 227-232.
75. Gambichler T, Skrygan M, Tomi N S et al. Br J Dermatol 2006: 155: 1275-1278.
76. Hata T R, Kotol P, Boguniewicz M et al. Br J Dermatol 2010: 163: 659-661.
77. Dressel S, Harder J, Cordes J et al. Exp Dermatol 2010: 19: 628-632.
78. Ballardini N, Johansson C, Lilja G et al. Br J Dermatol 2009: 161: 40-47.
79. De Koning H D, Kamsteeg M, Rodijk-Olthuis D et al. J Invest Dermatol 2011: 131: 263-266.
80. Ahrens K, Schunck M, Podda G-F et al. J Invest Dermatol 2011: 131: 443-452.
81. Mallbris L, Carlén L, Wei T et al. Exp Dermatol 2010: 19: 442-449.
82. Hata T R, Afshar M, Miller J et al. Exp Dermatol 2013: 22: 599-601.
83. Kanda N, Watanabe S. Immunobiology 2012: 217: 436-445.
84. Jansen P A M, Rodijk-Olthuis D, Hollox E J et al. PLoS ONE 2009: 4: e4725.
85. Zanger P, Holzer J, Schleucher R et al. J Infect Dis 2009: 200: 1907-1915.
86. Zanger P, Holzer J, Schleucher R et al. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2. Infect Immun 2010: 78: 3112-3117.
87. Percoco G, Merle C, Jaouen T et al. Exp Dermatol 2013: 22: 800-806.
88. Menzies B E, Kenoyer A. Infect Immun 2005: 73: 5241-5244.
89. Sawamura D, Goto M, Shibaki A et al. Gene Ther 2005: 12: 857-861.
90. Kisich K O, Howell M D, Boguniewicz M et al. J Invest Dermatol 2007: 127: 2368-2380.
91. Howell M D, Gallo R L, Boguniewicz M et al. Immunity 2006: 24: 341-348.
92. Wanke I, Steffen H, Christ C et al. J Invest Dermatol 2011: 131: 382-390.
93. Dinulos J G H, Mentele L, Fredericks L P et al. Clin diagnostic Lab Immunol 2003: 10: 161-166.
94. Simanski M, Gläser R, Harder J. Exp Dermatol 2014: 23: 230-231.
95. Jensen J M M, Ahrens K, Meingassner J et al. Exp Dermatol 2011: 20: 783-788.
96. Park K Y, Kim D H, Jeong M S et al. J Korean Med Sci 2010: 25: 766-771.
97. Felton S, Navid F, Schwarz A et al. Photochem Photobiol Sci 2013: 12: 29-36.
98. Kao J S, Fluhr J W, Man M Q et al. J Invest Dermatol 2003: 120: 456-464.
99. Kim M, Jung M, Hong S-P et al. Exp Dermatol 2010: 19: 501-510.
100. Kanda N, Watanabe S. Eur J Immunol 2008: 38: 1287-1296.
101. Routsias J G, Karagounis P, Parvulesku G et al. Peptides 2010: 31: 1654-1660.
102. Maisetta G, Di Luca M, Esin S et al. Peptides 2008: 29: 1-6.
103. Nuding S, Zabel L T, Enders C et al. Microbes Infect 2009: 11: 384-393.
104. Abou Alaiwa M H, Reznikov L R, Gansemer N D et al. Proc Natl Acad Sci 2014: 111: 18703-18708.
105. Yamasaki K, Schauber J, Coda A et al. FASEB J 2006: 20: 2068-2080.
106. Rippke F, Schreiner V, Doering T et al. Am J Clin Dermatol 2004: 5: 217-223.
107. Miajlovic H, Fallon P G, Irvine A D et al. J Allergy Clin Immunol 2010: 126: 1184-1190 e3.
108. Van Drongelen V, Haisma E M, Out-Luiting J J et al. Clin Exp Allergy 2014: 44: 1515-1524.
109. Arikawa J, Ishibashi M, Kawashima M et al. J Invest Dermatol 2002: 119: 433-439.
110. Jinnestål C L, Belfrage E, Bäck O et al. Int J Dermatol 2014: 53: 27-33.
111. Wanke I, Skabytska Y, Kraft B et al. Exp Dermatol 2013: 22: 153-155.
112. Sørensen O E, Thapa D R, Rosenthal A et al. J Immunol 2005: 174: 4870-4879.
113. Prado-Montes de Oca E, García-Vargas A, Lozano-Inocencio R et al. Int Arch Allergy Immunol 2007: 142: 211-218.
114. Kim E, Lee J-E, Namkung J-H et al. J Dermatol Sci 2009: 54: 25-30.
115. Albanesi C, Fairchild H R, Madonna S et al. J Immunol 2007: 179: 984-992.
116. Harder J, Gläser R, Schröder J-M. Endocr Metab Immune Disord Drug Targets 2007: 7: 75-82.
117. Nakatsuji T, Gallo R L. J Invest Dermatol 2012: 132: 887-895.
118. Wang Z, Wang G. Nucleic Acids Res 2004: 32: D590-D592.
119. Duits L A, Ravensbergen B, Rademaker M et al. Immunology 2002: 106: 517-525.
120. Fulton C, Anderson G M, Zasloff M et al. Expression of natural peptide antibiotics in human skin. Lancet 1997: 350: 1996-1997.
121. Ali R S, Falconer A, Ikram M et al. J Invest Dermatol 2001: 117: 106-111.
122. Supp D M, Karpinski A C, Boyce S T. Burns 2004: 30: 643-648.
123. Krishnakumari V, Rangaraj N, Nagaraj R. Antimicrob Agents Chemother 2009: 53: 256-260.
124. Oren A, Ganz T, Liu L et al. Exp Mol Pathol 2003: 74: 180-182.
125. Harder J, Schroder J M. J Leukoc Biol 2005: 77: 476-486.
126. Lai Y, Villaruz A E, Li M et al. Mol Microbiol 2007: 63: 497-506.
127. Hoover D M, Wu Z, Tucker K et al. Antimicrob Agents Chemother 2003: 47: 2804-2809.
128. Sahly H, Schubert S, Harder J et al. Antimicrob Agents Chemother 2003: 47: 1739-1741.
129. Maisetta G, Batoni G, Esin S et al. Antimicrob Agents Chemother 2006: 50: 806-809.
130. Braff M H, Di Nardo A, Gallo R L. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 2005: 124: 394-400.
131. Larrick J W, Hirata M, Shimomoura Y et al. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob Agents Chemother 1993: 37: 2534-2539.
132. Regenhard P, Leippe M, Schubert S et al. Vet Microbiol 2009: 136: 335-340.
133. Michalek M, Gelhaus C, Hecht O et al. Dev Comp Immunol 2009: 33: 740-746.
134. Lai Y-P, Peng Y-F, Zuo Y et al. Biochem Biophys Res Commun 2005: 328: 243-250.
135. Schittek B. J Innate Immun 2012: 4: 349-360.
136. Schalkwijk J, Van Vlijmen-Willems I M J J, Alkemade J A C et al. J Invest Dermatol 1993: 100: 390-393.
137. Alkemade J A, Molhuizen H O, Ponec M et al. J Cell Sci 1994: 107: 2335-2342.
138. Simpson A J, Maxwell A I, Govan J R W et al. FEBS Lett 1999: 452: 309-313.
139. Martínez A, Elsasser T H, Muro-Cacho C et al. Endocrinology 1997: 138: 5597-5604.
140. Allaker R P, Zihni C, Kapas S. FEMS Immunol Med Microbiol 1999: 23: 289-293.
141. Allaker R P, Grosvenor P W, McAnerney D C et al. Peptides 2006: 27: 661-666.
142. Niyonsaba F, Ogawa H. J Dermatol Sci 2005: 40: 157-168.
143. Ogawa H. J Dermatol 1975: 2: 45-50.
144. Ogawa H, Miyazaki H, Kimura M. J Invest Dermatol 1971: 57: 111-116.
145. Garcia J R C, Krause A, Schulz S et al. FASEB J 2001: 15: 1819-1821.